Bridging therapy and risk of major bleeding and thrombosis in continuous-flow left ventricular assist device patients: a quasi-experimental study

25 August 2023 (16:20 - 16:30)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Robin Roovers

Leiden University Medical Center, Leiden (Netherlands (The))

5 More presentations in this session

Presentation thumbnail

Non-HLA autoantibodies supplement donor specific antibodies in predicting graft survival after heart transplantation

Doctor G. Oh (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Role of NTproBNP and donor-derived cell-free DNA in the diagnosis of acute rejection in heart transplant recipients: a prospective study

Doctor M. Jimenez-Blanco Bravo (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

Urinary proteomics signature of malignancy post heart transplantation is associated with mortality risk

Doctor Z. Zhang (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Transcatheter edge to edge repair of functional mitral regurgitation as bridge to heart transplantation: 2-years follow up results from MitraBridge international registry

Doctor C. Marcelli (Bologna, IT)

Abstract Slides Video

Presentation thumbnail

Transition from temporary microaxial left ventricular assist devices to durable mechanical circulatory support systems

Mr D. Lewin (Berlin, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Challenges and opportunities in heart transplantation and ventricular assist devices

The Event

Event poster

ESC Congress 2023

25 August 2023 16:20 CET

You may be interested in

Congress Presentation

Impact of delayed heparin bridging on bleeding and stroke after heartmate 3 left ventricular assist device implantation

Congress Presentation

Optimal anticoagulation strategy for left ventricular assist device patients undergoing thoracentesis: a retrospective study

Congress Session

Progress in advanced heart failure therapy